Economy
Agreement Inked To Establish Vaccines Factory In Khazaen City Worth RO20M
Khazaen Economic City signed an agreement with Opal For Biopharmaceuticals and Business Company to establish a factory for the production of biological human vaccines to the tune of RO20mn.
The first phase of the project will be set up on a total area of 37,000 square meters.

The agreement was signed by Eng. Salim Al Thuhli, CEO of Khazaen and Sa’ad Moosa Al Junaibi, Chairman of the Board of Directors of Opal For Biopharmaceuticals and Business Company.
Al Thuhli said that this project will be the first vaccines factory in Khazaen Economic City and it targets local and international markets. The agreement, Al Thuhli added, comes as part of Khazaen’s efforts in attracting local and international investments.
-
Dossier3 weeks agoDossier, 2026
-
Insurance2 months agoLiva Insurance Supports Community Wellness Through “Experience Oman – Muscat Marathon 2026”
-
OER Magazines2 months agoOER, January 26
-
Interviews2 months agoEXCLUSIVE INTERVIEW: TLS Rebranding Marks Strategic Leap Toward Innovation, Sustainability & Growth
-
Alamaliktistaad Magazines2 months agoAl-iktisaad, January 26
-
Banking & Finance3 weeks agoNational Finance Unveils Exclusive Ramadan Offers on Auto Financing
-
Banking & Finance3 weeks agoSohar International and Sohar Islamic Supports Over 100 Families in Al Wusta Governorate Through Its ‘Sohar Al Attaa’ Initiative
-
Banking & Finance2 months agoA New Platform for SME Growth: Oman Arab Bank Unveils Tumouhi
